East North Central region has the highest prevalence of vancomycin-resistant Enterococcus faecalis in the United States
UMass Chan Affiliations
Department of Medicine, Division of Infectious Diseases and ImmunologyDocument Type
Letter to the EditorPublication Date
2013-04-01Keywords
Enterococcus faecalisVancomycin Resistance
Amino Acids, Peptides, and Proteins
Bacteria
Bacterial Infections and Mycoses
Carbohydrates
Epidemiology
Immunology and Infectious Disease
Microbiology
Pharmaceutical Preparations
Therapeutics
Metadata
Show full item recordAbstract
We read the article of Hayakawa et al with great interest. The report describes the growing prevalence of vancomycin-resistant Enterococcus faecalis in Michigan, a state that also has the most reports of vancomycin-resistant Staphylococcus aureus. Similar findings were reported in the tigecycline evaluation and surveillance trial (TEST). During the 2004–2009 period, 4.6% of 3,753 E. faecalis isolates were vancomycin resistant, with the highest rates of 7.6% in the East North Central region of United States. Here we report rates and trends of vancomycin-resistant E. faecalis in the East North Central region compared with national rates from 1999 to 2010.Source
Gandra S, Braykov N, Laxminarayan R. East North Central region has the highest prevalence of vancomycin-resistant Enterococcus faecalis in the United States. Infect Control Hosp Epidemiol. 2013 Apr;34(4):443-5. doi: 10.1086/669872. Link to article on publisher's site
DOI
10.1086/669872Permanent Link to this Item
http://hdl.handle.net/20.500.14038/28887PubMed ID
23466924Related Resources
Rights
Publisher PDF posted as allowed by the publisher's author rights policy at http://www.press.uchicago.edu/journals/jrnl_rights.html#faq4.ae974a485f413a2113503eed53cd6c53
10.1086/669872